Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

JUBILANT GENERICS

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 4

FDA approve RANOLAZINE

Comment Full text

HIKMA

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 6

FDA approve DEXMEDETOMIDINE HYDROCHLORIDE

Comment Full text

JANSSEN BIOTECH

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 5

FDA approve GOLIMUMAB

Comment Full text

MSN

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 6

FDA approve RUFINAMIDE

Comment Full text

SCIEGEN PHARMS INC

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 5

FDA approve BUPROPION HYDROCHLORIDE

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 4

FDA approve FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE

Comment Full text

LEADING

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 3

FDA approve FROVATRIPTAN SUCCINATE

Comment Full text

BRISTOL MYERS SQUIBB

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 6

FDA approve APIXABAN

Comment Full text

ACTAVIS LABS UT INC

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 4

FDA approve BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

Comment Full text

ACCORD HLTHCARE

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 5

FDA approve ESOMEPRAZOLE SODIUM

Comment Full text
  • Previous
  • 9
  • 10
  • 11
  • 12
  • 13
  • Next

Search

News categories

  • Technical Exchange News(9055)
  • Event(407)
  • SEC News(143258)
  • FDA Approval(8415)
  • Company Report(721)
  • Business News(100327)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin